JSR Life Sciences in the news

JSR launches services firm for biosimilar development

• May 12, 2022

Selexis, Pandion Enter Antibody Service Agreement

• Jan 25, 2022

Selexis, Tallac to advance novel immunotherapies

• Jan 25, 2022

Selexis SA and BITT Enter Service Agreement

• Oct 29, 2021

Crown Bioscience Acquires OcellO

• Oct 29, 2021

Eurofins DiscoverX Certifies KBI Biopharma

• Oct 26, 2021

Selexis and KBI to advance Immatics program - BioProcess Insider

• Jul 13, 2021

KBI Biopharma enters commercial manufacturing deal with AM-Pharma

• Jun 21, 2021